Confirmation of Previously Identified Plasma MicroRNA Ratios for Breast Cancer Detection in a Nested Case-control Study Within a Screening Setting
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Giordano L, Gallo F, Petracci E, Chiorino G, Segnan N
. The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol. BMC Cancer. 2017; 17(1):785.
PMC: 5700540.
DOI: 10.1186/s12885-017-3784-5.
View
2.
Chiorino G, Petracci E, Sehovic E, Gregnanin I, Camussi E, Mello-Grand M
. Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort. Sci Rep. 2023; 13(1):12040.
PMC: 10368693.
DOI: 10.1038/s41598-023-38886-0.
View
3.
Aggarwal V, Priyanka K, Tuli H
. Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers. Mol Diagn Ther. 2020; 24(2):153-173.
DOI: 10.1007/s40291-020-00447-w.
View
4.
Deng Y, Zhu Y, Wang H, Khadka V, Ling Hu , Ai J
. Ratio-Based Method To Identify True Biomarkers by Normalizing Circulating ncRNA Sequencing and Quantitative PCR Data. Anal Chem. 2019; 91(10):6746-6753.
PMC: 6884007.
DOI: 10.1021/acs.analchem.9b00821.
View
5.
Koi Y, Tsutani Y, Nishiyama Y, Ueda D, Ibuki Y, Sasada S
. Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles. Cancer Sci. 2020; 111(6):2104-2115.
PMC: 7293081.
DOI: 10.1111/cas.14393.
View